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Abstract An experimental rat model was used to test the
hypothesis that in osteoporosis (OP) the molecular com-
position of the extracellular matrix in the fracture callus is
disturbed. OP was induced at 10 weeks of age by ovari-
ectomy and a vitamin D3-deﬁcient diet, and sham-operated
animals fed normal diet served as controls. Three months
later a closed tibial fracture was made and stabilized with
an intramedullary nail. After 3 and 6 weeks of healing, the
animals were killed and the fracture calluses examined
with global gene expression, in situ mRNA expression, and
ultrastructural protein distribution of four bone turnover
markers: osteopontin, bone sialoprotein, tartrate-resistant
acid phosphatase, and cathepsin K. Global gene expression
showed a relatively small number of differently regulated
genes, mostly upregulated and at 3 weeks. The four chosen
markers were not differently regulated, and only minor
differences in the in situ mRNA expression and ultra-
structural protein distribution were detected. Gene
expression and composition of fracture calluses are not
generally disturbed in experimental OP.
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Osteoporosis(OP)isamultifactorialmetabolicbonedisease
characterized by reduced bone density and quality, resulting
inlossofmechanical strengthandincreasedsusceptibilityto
fracture. Women undergo a rapid phase of bone loss starting
2–3 years before ovarian failure, remaining up to 5 years
after menopause, and in many cases with postmenopausal
OP as the ﬁnal outcome [1, 2]. However, whether and to
what extent this disrupted balance between bone formation
and bone resorption [3, 4] inﬂuences healing of fractures in
OP individuals remain to be answered.
Fracture healing is a complex process that takes place in
order to fully restore anatomic and functional structure
following injury, involving cell proliferation and differen-
tiation, chemotaxis, and synthesis of extracellular matrix
(ECM). Although delayed healing of femoral neck frac-
tures in OP patients has been reported [5], no studies
reporting impaired healing in OP compared to healthy age-
matched controls have been published. Due to ethical
concerns and multiple confounding factors, most studies
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mized (OVX) rat model has been approved by the FDA [6]
as a relevant model for the study of postmenopausal OP,
mimicking postmenopausal trabecular bone loss when
examined over relatively short periods of time. Impaired
fracture healing has been reported in this model in early [7]
and late [8] stages, as evaluated by radiographic, histo-
morphometric, and mechanical parameters. However, we
recently demonstrated preserved bone mineral density
(BMD) and mechanical strength of callus 6 weeks after
fracture in experimental OP [9], in line with the ﬁndings by
Kubo et al. [8] at the same time point. In support, Wheeler
et al. [10] report no difference between OVX and sham rats
in mechanical strength of callus at 4, 6, and 8 weeks after
fracture. Also, recent data support unaltered fracture heal-
ing mechanisms during OP [11]. Thus, data are conﬂicting
and, moreover, only a limited number of studies look into
the molecular events involved in fracture repair in OP.
An additional predictor in the development of postmen-
opausal OP is vitamin D deﬁciency, which also may inﬂu-
ence bone repair. Vitamin D deﬁciency is common among
womenwithOP[12]andwomenwithfracturesregardlessof
age [13], leading to accelerated bone resorption. In support,
OVX rats with vitamin D depletion develop site-speciﬁc
bone loss similar to what is observed in women with post-
menopausal OP [14]. Additionally, oral administration of
1,25(OH)2 vitamin D3 has recently been shown to improve
fracture healing in OVX rats [15]. Interestingly, both
estrogen [16] and vitamin D [17, 18] inﬂuence the expres-
sion and synthesis of ECM proteins, and such proteins play
important rolesinmediatingcellular functionandmay serve
as important modulators of bone regeneration.
Thus, we hypothesized that lack of estrogen and vitamin
D will inﬂuence global gene expression as well as the
synthesis and ultrastructural distribution of ECM molecules
in the fracture callus and, consequently, the capacity of
fracture repair. To test this hypothesis, we examined global
gene expression and in situ mRNA expression as well as
the ultrastructural protein distribution of two major phos-
phoproteins in bone, i.e., osteopontin (OPN) and bone
sialoprotein (BSP), and two osteoclast enzymes, i.e., tar-
trate-resistant acid phosphatase (TRAP) and cathepsin K
(CTK), in the callus 3 and 6 weeks after tibial fracture of
vitamin D-depleted OVX rats. Sham-operated, age-mat-
ched controls were used for comparison.
Methods
Animals and Tissue Preparation
All animal procedures were approved by the Norwegian
AnimalResearchAuthority.Theexperimentalanimalmodel
was the same as previously presented [9]. In brief, 43 female
Wistar rats (10 weeks of age with a mean body weight of
235 g [range 197–272]) were randomly assigned to two
groups: OVX-D (ovariectomy followed by vitamin D3-
deﬁcient diet and 3 months’ observation) and sham-treated
(abdominal skin incision and normal diet in the same period
of time). Bone loss was validated by dual-energy X-ray
absorptiometry (DXA) in vivo before a closed fracture was
made in the tibial midshaft and ﬁxed with an intramedullary
nail. For the fractured area, the value of the intramedullary
nail was subtracted. Animals were killed at 3 and 6 weeks
afterfracture,andbloodwascollectedbeforedeath.Animals
for microarray analyses were killed by a phenobarbital
overdose, and the dissected tibias were snap-frozen in liquid
nitrogen. In the remaining animals, tissue was ﬁxed by in
vivo perfusion of 0.1 M phosphate-buffered 2% PFA during
deep anesthesia, the tibias were dissected free from muscle
and soft tissue, and the nail was carefully removed from a
proximal port. Tibias were immersed in 2% PFA/0.5%
glutaraldehyde/0.1 M phosphate buffer and decalciﬁed in
7% EDTA/0.5% PFA. Bone samples for transmission elec-
tron microscopic (TEM) analyses were subjected to low-
temperature embedding in Lowicryl HM23 (Chemische
Werke Lowi, Waldkraiburg, Germany) according to our
established protocol [19]. Decalciﬁed bone samples for
histomorphometry and in situ hybridization (ISH) were
embedded in parafﬁn according to a routine protocol.
Histomorphometry
Sagittal sections were cut from the parafﬁn-embedded
decalciﬁed callus samples, placed on glass slides, and
stained with hematoxylin and eosin. To measure tissue
composition of callus, digital micrographs (920) were
sampled in a light microscope to cover the whole callus at
one side of the medullary cavity. A virtual square grid
(50 9 50 lm) was superimposed on the micrograph, and
point counting was performed for bone, cartilage, and other
connective/ﬁbrous tissue. To compare osteoblast (Ob.S)
and osteoclast (Oc.S) surfaces, ﬁve micrographs were
sampled per callus section (940) and parallel lines (50 lm
in between) were superimposed on each micrograph.
Intersection counting was performed and Ob.S/Oc.S was
calculated according to the standard histomorphometric
procedure. For each animal, two sets of micrographs were
sampled at two different tissue levels. The mean value was
used to compare differences between groups.
RNA Isolation
Calluses were cut from the tibial diaphyses and homoge-
nized in Trizol reagent (Invitrogen, Carlsbad, CA), and
total RNA was isolated according to the manufacturer’s
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puriﬁed using the RNeasy micro kit (Qiagen, Valencia,
CA). The concentration and quality of total RNA samples
were assessed by spectrophotometry and the 2100 Bioan-
alyzer (Agilent Technologies, Santa Clara, CA).
ISH
Total RNA was reverse-transcribed to cDNA using the
oligonucleotide primers listed in Table 1. cDNAs were
cloned with the Dual Promoter TA Cloning Kit (Invitro-
gen) and sequenced (Seqlab, Go ¨ttingen, Germany).
Digoxigenin (DIG)-conjugated complementary RNA
(cRNA) probes were synthesized with a DIG-labeling kit
(Roche Diagnostics, Oslo, Norway) using T7 or Sp6 RNA
polymerase to yield probes in the sense or antisense ori-
entation. For TRAP, cloning and DIG labeling were per-
formed as previously described [21, 22]. Hybridization was
performed by modiﬁcation of a previously described pro-
tocol [23]. Brieﬂy, dewaxed and proteinase K-digested
sections of parafﬁn-embedded callus samples were post-
ﬁxed in 4% PFA. Following prehybridization (60 min, RT)
in 50% formamide/29 SSC, sections were hybridized
(overnight, 42C) with 5 ng probe in 50% formamide/29
SSC/7.5% dextran sulfate. High-stringency washing was
performed, and unbound probe was removed by RNAse
treatment (Ambion, Austin, TX). Hybridized probes were
detected using an alkaline phosphatase (AP)-conjugated
sheep anti-DIG antibody followed by the AP substrate
nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl-
phosphate (Roche Diagnostics).
Immunohistochemistry and Immunogold Labeling
We cut 70-nm sections from Lowicryl HM23-embedded
tissue and mounted them on formvar-coated nickel grids,
and immunogold labeling was performed as previously
described [19]. Brieﬂy, after blocking with 5% BSA in
PBS, grid-mounted sections were incubated overnight with
the primary polyclonal antibodies: anti-BSP (Chemicon,
Temecula, CA), anti-TRAP (Immunodiagnostic Systems,
Boldon, UK), anti-CTK (Santa Cruz Biotechnology, Santa
Cruz, CA), and anti-OPN (raised in rabbits against a pep-
tide sequence of the N-terminal end of the molecule).
Bound antibodies were visualized by 90-min incubation
with 10-nm colloidal gold conjugated with protein A.
Nonspeciﬁc rabbit IgG was used as a negative control.
Analyses
Microarray
The analysis was performed essentially as previously
described [20], except that biotin-labeled cRNA probes
were hybridized to GeneChip
 Rat Genome 230 2.0 Array
(Affymetrix, High Wycombe, UK). The quality of the
RNA and cRNA probes was assessed by measuring the
ratio between the 50 and 30 mRNAs for b-actin and GAPDH
according to the Affymetrix-based test and found to be
highly satisfactory.
Light Microscopy and ISH
Light microscopy was performed on parafﬁn-embedded
callusspecimenshybridizedwithDIG-labeledcRNAprobes
for OPN, BSP, TRAP and CTK. Seven to 10 digital images
(920) were sampled per callus section. Point counting of
mRNA-positive cells facing bone surfaces was performed
using a semiautomatic image analyzer program (AnalySIS
pro; Digital Soft Imaging System, Munster, Germany) with
grid size of 25 9 25 lm[ 24]. In a parallel set of hematox-
ylin-stained sections, the corresponding callus area was
identiﬁedandthe total amountof osteoblastsandosteoclasts
attached to bone surfaces counted (920). The ratio of
mRNA-positive cells/total amount of bone surface cells was
calculated for each set of corresponding images.
TEM and Immunogold Analyses
Micrographs were obtained by systematic random sam-
pling of cells/surrounding matrix and analyzed using the
semiautomatic interactive image analyzer software Anal-
ySIS pro. All identiﬁed osteoclasts and at least four oste-
oblasts in one to three sections per animal were included in
the analyses. An osteoclast was deﬁned as a multinuclear
cell attached to a matrix surface with characteristic mem-
brane domains, i.e., rufﬂed border (RB) and/or clear zone
(CZ), and an abundance of mitochondria in their cytoplasm
[25]. An osteoblast was deﬁned as a mononuclear cell
attached to osteoid/bone matrix with a characteristic
abundance of endoplasmic reticulum and Golgi complexes.
A minimum of four images were sampled in each prede-
termined region according to our previous experience with
protein distribution for BSP, OPN, TRAP, and CTK [26,
27]. Osteoid, mineralization fronts/cement lines, and
woven bone matrix as well as osteoblasts and osteoclasts
were identiﬁed at low magniﬁcation (92,500); and
micrographs for gold particle measurements were sampled
Table 1 Primer sequences for DIG-labeled cRNA probes
Sequence
name
Sequence forward Sequence reverse
CTK 50-agacgcttacccgtatgtgg-30 50-tggagagaagggaagcagag-30
BSP 50-atggagatggcgatagttcg-30 50-tgaaacccgttcagaaggac-30
OPN 50-ctctgatcaggacagcaacg-30 50-tcagggcccaaaacactatc-30
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123at high magniﬁcation (943,000). Gold particle density was
calculated in the regions of interest (ROIs) according to the
structural limits in the micrographs. Sections incubated
with gold-labeled antibodies against BSP and OPN were
analyzed with respect to both osteoblasts and osteoclasts,
while only osteoclasts were studied in TRAP- and CTK-
labeled sections. The results are based on the analysis of up
to 42 and 24 osteoclasts at 3 and 6 weeks of healing,
respectively. For osteoblasts, a minimum of 20 cells were
analyzed in each group at 3 weeks and 12 at 6 weeks.
Statistics
Morphological results are given as means with standard
deviation (SD)inparentheses.One-way analysisofvariance
(ANOVA) and multivariate analysis of variance (MANO-
VA) were used for light and electron microscopic data,
respectively. For the latter, interest was focused on whether
the overall distribution pattern for each of the four proteins
differed between the groups. Thus, for a protein, only dif-
ferences in overall comparison between the groups using
MANOVA, and not differences in tests between subjects,
were considered. P\0.05 was considered signiﬁcant.
Statistical Analysis of Gene Expression Proﬁling
The 16 scanned chip images originating from the bone
samples were processed using GCOS 1.4 (Affymetrix). The
CEL ﬁles were imported into Array Assist software
(v5.2.0; Iobion Informatics, La Jolla, CA) and normalized
using the PLIER (probe logarithmic intensity error) algo-
rithm in Array Assist to calculate relative signal values for
each probe set. In order to ﬁlter for low signal values, the
MAS5 algorithm in Array Assist was used to create a data
set of absolute calls, showing the number of present and
absent calls for each probe set. The ﬁltration was per-
formed by eliminating probe sets containing C13 absent
calls across the data set, resulting in a reduction of probe
sets from 31,099 to 21,947. For expression comparisons of
different groups, proﬁles were compared using a paired
t-test. The results are expressed as fold changes (FCs), i.e.,
ratio of mean signals between compared groups. Gene lists
were generated with the criteria of P\0.05 and FC C 2.
Results
Animal Model
After randomization but prior to OVX and introduction of
diet, the mean body weight was 4.7% lower in the OVX-D
group compared to sham (P = 0.02). However, despite
pair feeding, the OVX-D group gained more weight
compared to sham-treated. The mean body weight was
8.6% and 12.9% higher in the OVX-D group after 3 and
6 weeks, respectively (P\0.001).
All animals in the OVX-D group presented vitamin D3
and estrogen deﬁciency. 25(OH)D B 25 nmol/l in serum
was considered as vitamin D deﬁciency, and all animals in
theOVX-Dgrouppresentedlevelsof25(OH)D B 18 nmol/
l, out of which 94.4% showed undetectable (i.e., B13 nmol/
l) levels of 25(OH)D. Abolished ovarian function was
deﬁned as serum estradiol \0.10 nmol/l (Hormone Labo-
ratory, Aker University Hospital, Oslo, Norway). All OVX-
D animals presented serum estradiol levels below the
reference values in complete loss of ovarian function (i.e.,
B0.08 nmol/l).
Trabecular bone loss was conﬁrmed by DXA showing
decreased BMD in the vertebra and the femoral neck in
OVX-D compared to sham-treated (P\0.001) (Fig. 1a,
data from [9]).
Callus BMD
DXA measurements showed no signiﬁcant differences 2, 3,
and 6 weeks after fracture (Fig. 1b, data from [9]).
Callus Morphology and Histomorphometry
Fracture calluses demonstrated intense osteogenesis after
3 weeks in both groups. However, there was large interin-
dividual variation in size and ratio of intramembranous to
endochondral bone formation; some calluses exhibited
mainly cartilage/ﬁbroustissuein the space between the areas
of subperiosteal bone formation, while others exhibited
predominantlyintramembranousbone formationbeneaththe
periosteum adjacent to the fracture site (Fig. 2). Resorbing
clasts were observed on both cartilaginous and osseous sur-
faces. At 6 weeks of healing, the same light microscopic
heterogeneity was evident. However, a general tendency
toward a decline in remodeling activity was observed.
Histomorphometry showed overall different callus
composition in the OVX-D group after 3 weeks compared
to sham (P = 0.02), with more woven bone and carti-
lage but less ﬁbrous/connective tissues (Table 2). After
6 weeks, no overall difference was present. Furthermore,
no differences between the groups were detected in Ob.S/
Oc.S at any time point (Table 3).
Gene Proﬁling
At 3 weeks of healing, 155 annotated genes and 88
expressed sequence tags (ESTs) were differently regulated
in OVX-D vs. sham, out of which 35 genes were down-
regulated and 120 upregulated. At 6 weeks, 22 genes and
eight ESTs were differently regulated, out of which six
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(Fig. 3; Supplementary Table S1). No signiﬁcant differ-
ences in the mRNA levels for OPN, BSP, TRAP, or CTK
between the groups or between the different time points
were detected (Table 4). Among genes with suggested or
known roles in bone metabolism, ﬁbroblast growth factor
23 (FGF23) was downregulated (P = 0.02) and interleukin
17 (IL-17) receptor A was upregulated (P = 0.01) in the
OP group at 3 weeks.
Localization of OPN, BSP, TRAP, and CTK mRNA
OPN and BSP mRNA were detected predominantly in
osteoblastic cells and in some chondrocytes in the bone–
cartilage transitional zone but were undetectable in
resorbing multinuclear cells. However, BSP mRNA
expression in osteoclast progenitors cannot be excluded.
CTK and TRAP mRNA were detected in multinucleated
cells attached to bone/cartilage surfaces. In addition, sev-
eral nonattached mononuclear cells, presumably osteoclast
progenitors, were positive (Fig. 4).
Ratios of mRNA-Expressing Cells on Bone Surfaces
Compared to sham-treated animals, OVX-D animals
exhibited an increased ratio of OPN mRNA-expressing cells
at 3 weeks (P = 0.05) but a decreased ratio of BSP mRNA-
expressing cells at 6 weeks (P = 0.01). Ratios for TRAP or
CTK did not differ between the two groups. In the OVX-D
group, ratios for BSP (P = 0.04), OPN (P = 0.01), and
CTK (P = 0.04) decreased from 3 to 6 weeks. No differ-
ences between the time points were observed among these
mRNAs for sham-treated animals (Table 5).
Ultrastructural Protein Distribution
The most intense accumulation of markers for both BSP
and OPN was observed at electron-dense extracellular
areas representing mineralization front/cement lines
(Fig. 5) and, to a lesser extent, diffusely spread in the
mineralized matrix of woven bone. BSP exhibited a char-
acteristic pattern, with label being localized to discrete sites
in the bone matrix corresponding to areas known to rep-
resent early mineral deposition [28] (Fig. 5b). Both BSP
and OPN labeling showed a tendency toward increased
intensity in the matrix facing the CZ of osteoclasts, the
latter being most pronounced. No signal for BSP or OPN
was found in the cartilaginous areas. Immunoreactivity for
TRAP and CTK was consistently increased in the osteo-
clast cytoplasm and partly in the matrix facing the RB
(Fig. 6). Lower levels were observed in the matrix facing
the CZ. Intraluminal labeling of vessels was used as a
measure of nonspeciﬁc binding/background and was low
throughout the experiments, as was the nuclear labeling.
Quantitative Immunogold Analysis
No signiﬁcant differences were found for the overall
quantitative immunogold distribution of OPN and BSP,
with respect to either groups or time points (Table 6).
CTK showed a different distribution with respect to
osteoclasts between the groups after 3 weeks (P = 0.05),
with generally increased labeling intensity in all compart-
ments measured for osteoclasts in the OVX-D animals.
Moreover, CTK labeling in the sham-treated animals dif-
fered from 3 to 6 weeks (P = 0.01). TRAP distribution did
not differ between the groups or between different time
points. Interestingly, TRAP labeling accumulated in the
Fig. 1 DXA measurements of BMD in femoral neck (upper panel)
and lumbar vertebrae (lower panel)( a) and fracture area (b)[ 9]. BMD
in the femoral neck was signiﬁcantly lower in OVX-D animals
compared to sham at all measured time points (*P\0.01). There
were no signiﬁcant differences between the right and left femoral
neck. BMD in the fractured area did not differ signiﬁcantly at any
time points
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123matrix facing the RB of osteoclasts at 3 weeks in both
groups but not at 6 weeks (Table 7).
Discussion
The present study addresses fracture healing in vitamin
D-depleted OVX rats at the molecular level over a 6-week
period. This is a well-established model, and in a recent
study we observed bone loss in femoral neck and lumbal
vertebrae but, somewhat surprisingly, little effect on the
mechanical strength of healing fractures [9]. Estrogen and
vitamin D exert their effects on bone in a spatial manner,
which differs between metabolically active trabecular bone
and weight-bearing cortical bone. Although vitamin D ini-
tially was reportedto stimulate bone resorption in vitro [29],
more recent in vivo ﬁndings indicate that active vitamin D
analogues rather have an inhibitory effect on bone resorp-
tion, at least in a state of high turnover [30]. This inhibitory
Fig. 2 Light micrographs of the
fracture/callus area in the OVX-
D and sham groups at 3 and
6 weeks of healing. After
3 weeks OVX-D (a) and sham
(b) appeared with bridging of
callus gap and periosteal callus.
After 6 weeks OVX-D (c) and
sham (d) presented a more
remodeled callus, although
heterogeneity still was present.
Parafﬁn-embedded section,
H&E staining, 94 magniﬁcation
Table 2 Callus histomorphometry: callus composition
Week Group n Woven bone Cartilage Fibrous
connective tissue
3 OVX-D* 6 0.40 ± 0.13 0.34 ± 0.054 0.26 ± 0.14
Sham 7 0.37 ± 0.21 0.29 ± 0.12 0.35 ± 0.28
6 OVX-D 5 0.56 ± 0.052 0.24 ± 0.089 0.19 ± 0.10
Sham 3 0.37 ± 0.18 0.34 ± 0.16 0.29 ± 0.32
Values are mean (%) ± SD. * Signiﬁcantly different in overall
composition compared to sham (P = 0.02)
Table 3 Callus histomorphometry: cell types covering callus
surfaces
Week Group n Ob.S Oc.S Other cells/
eroded surface
3 OVX-D 6 0.78 ± 0.029 0.064 ± 0.029 0.16 ± 0.044
Sham 7 0.72 ± 0.060 0.10 ± 0.055 0.18 ± 0.08
6 OVX-D 5 0.72 ± 0.080 0.040 ± 0.037 0.24 ± 0.071
Sham 3 0.53 ± 0.17 0.13 ± 0.084 0.34 ± 0.11
Values are mean (%) ± SD. Ob.S, osteoblast surface; Oc.S, osteo-
clast surface
Fig. 3 Differentially expressed genes in the OVX-D group. DNA
microarray analysis showed a larger number of annotated genes
differently regulated in the OVX-D group compared to sham, the
majority in an increased fashion and mostly after 3 weeks of healing.
No genes encoding collagens or known matrix proteins were
differentially regulated. Fold change C2, P B 0.05
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a similar manner, estrogen deﬁciency following OVX
resultsinbonelossatdiscretesitesintheskeleton,withmost
pronounced effect on trabecular bone [32].
Several genes associated with signal transduction, lipid
and protein metabolism, ionic and protein transport, and
neuropeptide and G-protein signaling were differently
regulated in our OVX-D rat model. Many of these pro-
cesses represent metabolic systems capable of maintaining
bone homeostasis and tissue turnover. Most genes were
expressed in an increased fashion in OVX-D compared to
sham, in line with other reports on gene proﬁling of intact
bone in OP [33]. Interestingly, no signiﬁcant differences
were detected among genes encoding noncollagenous
proteins (NCPs) with known functions in bone metabolism.
Table 4 Gene proﬁling of TRAP, OPN, BSP, and CTK
Gene ID Gene name Gene symbol FC
OVX-D vs. sham
3 weeks 6 weeks
1367942_at Tartrate-resistant acid phosphatase 5 (TRAP) Acp5 1.26 1.22
1367581_a_at Secreted phosphoprotein 1 (OPN) Spp1 1.74 0.83
1368416_at Integrin binding sialoprotein (BSP) Ibsp 0.91 1.00
1369947_at Cathepsin K (CTK) Ctsk 1.74 0.91
DNA microarray showed no differences between the OVX-D and sham groups in gene expression for the four bone remodeling markers TRAP,
OPN, BSP, and CTK. FC (fold change) C2
Fig. 4 OPN, BSP, TRAP, and
CTK mRNA-positive cells in
fracture callus at 3 weeks
visualized by ISH. OPN mRNA
(a) and BSP mRNA (c) positive
osteoblasts, TRAP mRNA (b)
and CTK mRNA (d) positive
osteoclasts (arrows). WB,
woven bone. CB, cortical bone.
Parafﬁn-embedded sections,
920 magniﬁcation
Table 5 Semiquantitative ISH for TRAP, CTK, OPN, and BSP
mRNA Group n 3 weeks 6 weeks
TRAP OVX-D 6/5 0.20 ± 0.14 0.068 ± 0.053
Sham 7/4 0.11 ± 0.052 0.18 ± 0.14
CTK OVX-D 7/5 0.17 ± 0.095** 0.059 ± 0.032
Sham 7/4 0.18 ± 0.094 0.14 ± 0.14
OPN OVX-D 7/5 0.33 ± 0.15*
,** 0.12 ± 0.047
Sham 7/4 0.19 ± 0.059 0.12 ± 0.085
BSP OVX-D 7/5 0.21 ± 0.14** 0.022 ± 0.034
Sham 7/4 0.32 ± 0.19 0.18 ± 0.089*
Results are mean ± SD. n, number of animals in the OVX-D and
sham groups, respectively
* Signiﬁcant difference between the groups (P B 0.05); ** Signiﬁ-
cant difference between 3 and 6 weeks in the group (P B 0.05)
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regulated compared to 6 weeks; and consequently, changes
in the healing pattern in OP would be expected in early
stages. Among the differently regulated genes, the genes
for IL-17 receptor A and FGF23 were up- and downregu-
lated in OVX-D after 3 weeks. FGF23, a phosphaturic
hormone and part of the newly discovered hormonal bone–
parathyroid–kidney axis, is modulated by PTH, vitamin D,
and phosphate levels. The fact that 1,25(OH)2D3 upregu-
lates FGF23 gene expression in bone [34] and undetectable
serum levels of FGF23 are found in mice lacking the
vitamin D receptor [35], downregulation of FGF23 in the
OVX-D group could be explained by lack of dietary vita-
min D. However, downregulation due to vitamin D deﬁ-
ciency would be expected to be present also after 6 weeks.
Interestingly, FGF23 has recently been suggested as a
putative marker of bone healing; decreased FGF23 mRNA
expression is associated with delayed fracture healing in
ovine bone [36]. Thus, downregulation of FGF23 in our
model could also be associated with a possible delay in
fracture healing at an early stage, although this is not
supported by our other ﬁndings. IL-17 plays a role in bone
loss in rheumatoid arthritis [37]. However, IL17RA null
mice exhibit more pronounced bone loss compared to wild-
type mice following OVX [38]; and thus, the role of this
interleukin and its receptor seems diverse. Our observa-
tions call for further studies on the role of FGF23 and
IL17RA during fracture healing in osteoporotic bone.
In our molecular studies we focused on four molecules
with roles in tissue turnover taking place in the callus and,
putatively, inﬂuenced by lack of estrogen and vitamin D
depletion. For example, OPN is suggested to play roles
both during osteoclast development/activity [39] and
during matrix mineralization [40]. Furthermore, OPN null
mice are resistant to OVX-induced bone loss [41] and
display disturbed fracture healing [42], suggesting a role
for OPN during estrogen deﬁciency-related bone loss as
well as in bone repair. Moreover, OPN is under the inﬂu-
ence of both estrogen and vitamin D [16, 18].
mRNA expression for OPN, BSP, TRAP, and CTK in
cell types was distributed as previously described in intact
bone tissue [21, 26, 43]. OVX-D animals presented an
increased ratio of OPN mRNA-expressing cells and a
decreased ratio of BSP mRNA-expressing cells at 3 weeks
and a signiﬁcantly reduced ratio for BSP after 6 weeks of
healing. These observations are in line with the reported
inverse regulatory role of vitamin D for these proteins in
vivo [44]. The observed increase in OPN and subsequent
decline in BSP could possibly indicate suppressed osteo-
blastic differentiation in the OVX-D group.
In OVX-D rats at 3 weeks relative to 6 weeks, there was
a signiﬁcant decline in the ratio of cells expressing mRNA
for OPN, BSP, and CTK but not that for TRAP. Thus, the
decreased number of cells producing these bone turnover
biomarkers in the OVX-D group at 6 vs. 3 weeks indicates
a decline in synthetic activity/bone remodeling and a more
remodeled callus. The latter supports the ﬁnding of Cao
et al. [45] after 16 weeks of healing of a histologically
more mature callus with preserved mechanical properties
in OP vs. sham rats. Furthermore, these authors report no
differences in healing after 6 weeks, in line with our
results.
Quantitative immunoelectron microscopy showed only
minor differences in labeling (Tables 5, 6, 7). The apparent
inconsistency between our ISH and immunogold data is
most likely due to the fact that the two data sets represent
Fig. 5 Characteristic ultrastructural protein distribution of OPN and
BSP. Micrographs of low-temperature embedded callus tissue after
3 weeks of healing incubated with gold-conjugated rabbit anti-rat
antibodies against OPN and BSP. Immunogold signaling for OPN (a)
with distinct accumulation along a cement line (arrows) as previous
described [52]. Intense BSP signaling (b) at early focus of mineral-
ization, i.e., ‘‘mineralization noduli’’ (arrows). OC, osteocyte cana-
liculi. Lowicryl HM23-embedded, 943,000 magniﬁcation
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123different aspects of callus turnover: while ISH data repre-
sent mRNA expression and thus protein synthesis, immu-
nogold data reﬂect the present amount of protein in the
tissue, which is the net result of synthesis, secretion, and
degradation. That only minor differences of protein syn-
thesis and tissue distribution were detected between the
groups is supported by other studies [46, 47]. Interestingly,
also recent studies of gross mechanisms in fracture healing
in OVX rats [11] and transgenic mice [48] support our
ﬁndings.
As with any animal model, there are limitations in
simulating clinically relevant conditions. The calluses
showed considerable heterogeneity both by macroscopic
appearance and by histology, which was also reﬂected by
large standard deviations in histomorphometric and BMD
measurements. Except for a signiﬁcant difference in tissue
composition after 3 weeks, where the OP group presented
calluses comprising more bone and cartilage and less
ﬁbrous tissue compared to sham, there was no systematic
difference between the groups with respect to Ob.S/Oc.S,
BMD, or histomorphometric parameters. Mechanical
instability during fracture healing promotes cellular dif-
ferentiation in the direction of endochondral bone for-
mation [49], and variable degrees of fracture ﬁxation in
our experiment may explain the heterogeneity in the
callus sample. It should be noted that since mechanical
stress inﬂuences the mRNA expression in bone cells [50],
this may have inﬂuenced our results by causing a rela-
tively large variation among the samples. Furthermore,
minimal-trauma fractures in OP patients are mostly
localized to the proximal femur, vertebral column, and
distal forearm [51], i.e., areas of high trabecular to cor-
tical ratio. Thus, the present study concerns fracture
healing in cortical bone, and it is possible that this type of
bone healing is less inﬂuenced by estrogen and vitamin D
deﬁciency.
Fig. 6 Characteristic
ultrastructural protein
distribution of CTK and TRAP.
Micrographs of low-temperature
embedded callus tissue after
3 weeks of healing showing an
active resorbing osteoclast
attached to a bone surface (a)
(91,900). Micrographs sampled
at the rufﬂed border of the
osteoclast in (a) at higher
magniﬁcation (943,000),
incubated with gold-conjugated
rabbit anti-rat antibodies against
CTK (b) and TRAP (c).
Immunogold signaling for both
CTK and TRAP showed
accumulation in the osteoclast
cytoplasm and in the ECM
facing the rufﬂed border.
Lowicryl HM23-embedded
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123In summary, several genes are differently regulated in
OP induced by OVX and vitamin D depletion, mostly in an
early stage and the majority in an increased fashion,
although no genes encoding NCPs with known function in
bone metabolism were differently expressed. Against the
background of only minor differences in the synthesis and
protein expression of OPN, BSP, TRAP, and CTK in callus
between OVX-D and sham-treated animals, our results
suggest that the molecular composition of the fracture
callus is not markedly skewed in OP.
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